Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 9c, provides guidance

Zimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $2.07, $0.09 better than the analyst estimate of $1.98. Revenue for the quarter came in at $2.08 billion versus the consensus estimate of $2.06 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2025 EPS of $8.10-$8.30, versus the consensus of $7.99.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
• Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance